Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 171   

Articles published

BMY 56.56 +0.12 (0.21%)
price chart
Bristol-Myers Squibb to Take Part in Cowen and Company 37
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) will present at the Cowen and Company 37th Annual Global Health Care Conference on Monday, March 6, 2017, in Boston.
Exelixis (EXEL), Bristol-Myers Squibb (BMY) Enter Clinical Collaboration for ...  StreetInsider.com
Bristol-Myers Squibb Company (BMY) Earns Buy Rating from Argus  Sports Perspectives
Carl Icahn Takes Stake in Bristol-Myers Squibb
Billionaire activist investor Carl Icahn has taken a stake in pharmaceutical giant Bristol-Myers Squibb. WSJ's David Benoit and Tanya Rivero discuss the reasons behind Icahn's move, which came on the same day the company made efforts to appease ...
Carl Icahn swoops in, takes stake in Bristol-Myers Squibb  MarketWatch
Carl Icahn's Next Target: Bristol-Myers Squibb  Forbes
Bristol-Myers: Buyout Bound?
Bristol-Myers Squibb (NYSE:BMY) has quickly become one of the hottest names in pharma after attracting two big name activist investors.
Searle & Co. Buys Exxon Mobil, Bristol-Myers Squibb Company, Bank of ...  GuruFocus.com
Bristol-Myers (BMY) Up 20.5% Since Earnings Report: Can It Continue?  Yahoo Finance
Bristol-Myers Squibb (BMY) Adds Columbia University Medical Center and Peter ...
Bristol-Myers Squibb Company (NYSE: BMY) today announced that Columbia University Medical Center and Peter MacCallum Cancer Centre (Peter Mac) have joined the International Immuno-Oncology Network (II-ON), a global peer-to-peer collaboration ...
National Agreement Reached between Pan-Canadian Pharmaceutical Alliance and ...
MONTREAL, Feb. 10, 2017 /CNW/ - Bristol-Myers Squibb Canada Co. today announced that the company has reached an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for the immuno-oncology treatment OPDIVO�, bringing patients ...
Agreement brings access to Opdivo closer for Canadians  The Pharma Letter (registration)
Bristol-Myers Squibb Appoints Three New Independent Directors
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has appointed Robert J. Bertolini, Matthew W. Emmens and Theodore R. Samuels to its Board of Directors, effective immediately.
Company Update (NYSE:BMY): Bristol-Myers Squibb Co Wins FDA Approval For ...
Bristol-Myers Squibb Co (NYSE:BMY) announced the U.S. Food and Drug Administration (FDA) has approved Opdivo injection, for intravenous use for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease ...
Bristol-Myers' Injectable Opdivo Gets FDA Approval for mUC  Yahoo Finance
UPDATE: Bristol-Myers Squibb (BMY) Gains FDA Accelerated Approval for Opdivo ...  StreetInsider.com
Form 3 BRISTOL MYERS SQUIBB CO For: Feb 21 Filed by: Emmens Matthew
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here. FORM 3, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
Jana Partners Buys HD Supply Holdings, Bristol-Myers Squibb Company ...
Jana Partners initiated holdings in Bristol-Myers Squibb Company. The purchase prices were between $49.23 and $59.61, with an estimated average price of $54.67.
These 2 Factors Sent Bristol-Myers Squibb Co. Tumbling by 16% in January
Shares of global drug giant Bristol-Myers Squibb (NYSE: BMY) were hammered in January, falling 16% according to data from S&P Global Market Intelligence.
3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Visa Inc (V ...  Investorplace.com
Price Target Estimates Under Analyst's Radar: Bristol-Myers Squibb Co ...  Post Registrar